At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Press Releases

Press Releases

All Releases
View Summary Amicus Therapeutics Prices Underwritten Offering of Common Stock
Nov 18, 2014
PDF 11.9 KB
View Summary Amicus Therapeutics Announces Public Offering of Common Stock
Nov 17, 2014
PDF 11.8 KB
View Summary Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology
Nov 15, 2014
PDF 20.4 KB
View Summary Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates
Nov 6, 2014
PDF 29.6 KB
View Summary Amicus Therapeutics Announces Timing of Third Quarter 2014 Financial Results, Upcoming Scientific Conference and Other Corporate Updates
Nov 3, 2014
PDF 11.4 KB
View Summary Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011
Oct 19, 2014
PDF 17.7 KB
View Summary Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable
Sep 30, 2014
PDF 8.1 KB
View Summary Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
Aug 20, 2014
PDF 68.2 KB
View Summary Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
Aug 7, 2014
PDF 32.3 KB
View Summary Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
Jul 31, 2014
PDF 10.5 KB
View Summary Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
Jun 30, 2014
PDF 19.0 KB
View Summary Amicus Therapeutics to Present at UBS Global Healthcare Conference
May 14, 2014
PDF 9.3 KB
View Summary Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates
May 5, 2014
PDF 33.7 KB
View Summary Amicus Therapeutics to Announce First Quarter 2014
May 1, 2014
PDF 8.6 KB
View Summary Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011
Apr 29, 2014
PDF 27.6 KB
View Summary Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference
Mar 27, 2014
PDF 9.3 KB
View Summary Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates
Mar 3, 2014
PDF 32.5 KB
View Summary Amicus Therapeutics Appoints Jay A. Barth, MD as Chief Medical Officer and Promotes Bradley L. Campbell to Chief Operating Officer
Mar 3, 2014
PDF 13.8 KB
View Summary Amicus Therapeutics to Present at Cowen and Company 34th Annual Health Care Conference
Feb 27, 2014
PDF 9.4 KB
View Summary Amicus Therapeutics, Inc. [FOLD] to Ring The NASDAQ Stock Market Closing Bell
Feb 27, 2014
PDF 12.7 KB
Showing 1-20 of 225 Page: 1 2 3 4 5 ... 12  Next 20

Copyright © 2014 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy